| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.28 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |